Compounds > deferoxamine

deferoxamine and alprostadil

deferoxamine has been researched along with alprostadil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Hansen, TW; Knisely, AS; Kocoshis, SA; Reyes, J; Rosh, J; Sigurdsson, L1
Fujita, K; Kainuma, S; Kozawa, O; Kuroyanagi, G; Matsushima-Nishiwaki, R; Ohguchi, R; Otsuka, T; Tokuda, H; Yamamoto, N1

Other Studies

3 other study(ies) available for deferoxamine and alprostadil

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies.
    Journal of pediatric gastroenterology and nutrition, 1998, Volume: 26, Issue:1

    Topics: Acetylcysteine; Alprostadil; Antioxidants; Chelating Agents; Deferoxamine; Hemochromatosis; Humans; Infant, Newborn; Liver Transplantation; Retrospective Studies; Selenium; Treatment Outcome; Vitamin E

1998
Attenuation of prostaglandin E1‑induced osteoprotegerin synthesis in osteoblasts by normoxic HIF inducers.
    Molecular medicine reports, 2017, Volume: 15, Issue:4

    Topics: Alprostadil; Animals; Cell Line; Deferoxamine; Fabaceae; Hypoxia-Inducible Factor 1; Interleukin-6; MAP Kinase Kinase 4; Mice; Mimosine; Osteoblasts; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; RNA, Messenger

2017